| Literature DB >> 26649229 |
Anjuman Ara Begum1, D M Jakaria1, Sharif Md Anisuzzaman1, Mahfuzul Islam1, Siraje Arif Mahmud2.
Abstract
Probiotics containing food supplements available in Bangladesh market were identified and collected for assessment. To assess their label claim, they were resuspended into sterile distilled water. Then, series dilutions of each sample solution were prepared and immediately plated out, in duplicate, into De Man Rogosa Sharpe (MRS) agar. These plates were then incubated at 37°C for 48 hours and colonies were counted. Viable cell numbers stated on the labels were compared with actual viable cell numbers. To assess the viability of the probiotics included in the products, probiotic strains were isolated from each of the four products and screened for inhibitory activity against six indicator strains. It was surprisingly found that although the viable cell numbers of all supplements were three to four log cycles lower than label claim of the products, however, this problem did not affect the inhibitory activity of the probiotic strains against indicator strains according to in vitro assessment. Legislation and regulation regarding prebiotic-probiotic containing products should be built up in Bangladesh to ensure quality products supply to the consumers. Moreover, manufacturers of probiotic containing products should take the responsibility for providing the consumer with scientifically and legally correct information.Entities:
Year: 2015 PMID: 26649229 PMCID: PMC4663338 DOI: 10.1155/2015/763796
Source DB: PubMed Journal: J Pharm (Cairo) ISSN: 2090-9918
Comparison of the actual viable cell numbers with the claims on the tables of 4 probiotic supplements available in Bangladesh market.
| Supplement | Viable cell numbers stated on the label of the supplement (cfu/g) | Actual viable cell numbers identified (cfu/g) |
|---|---|---|
| 1 | 4 × 109 | 3.98 × 106 ± 0.03 |
| 2 | 5 × 109 | 3.19 × 105 ± 0.5 |
| 3 | 2.5 × 109 | 1.96 × 106 ± 0.04 |
| 4 | 1 × 1010 | 1 × 107 ± 0.01 |
Indicates values that are significantly lower than the corresponding viable cell numbers stated on the label of the supplement (P < 0.05 after independent sample t-test).
Figure 1A partial presentation of growth of probiotics of four different products.
Inhibitory activity of probiotic strains from 4 probiotic supplements against a panel of indicator strains.
| Human pathogen | Zone size (mm) | |||
|---|---|---|---|---|
| Supplement 1 | Supplement 2 | Supplement 3 | Supplement 4 | |
|
| 26–30 | 26–31 | 26–32 | 26–30 |
|
| 31–35 | 31–33 | 31-32 | 31–35 |
|
| 22–24 | 22–25 | 22-23 | 22–24 |
|
| 18–22 | 18–20 | 18–21 | 18–22 |
|
| 24–30 | 24–30 | 24–28 | 24–26 |
|
| 10–14 | 10-11 | 10–14 | 10–13 |